Michael Alfieri
Net worth: 9 225 $ as of 2026-09-29
Net worth: 9 225 $ as of 2026-09-29
Michael Alfieri is Chief Financial & Accounting Officer, Head-Finance at Aldeyra Therapeutics, Inc. since 2024.
Former roles include Controller & Executive Director-Finance at Anika Therapeutics, Inc. from 2010 to 2014, Vice President-Finance at Radius Health, Inc. from 2017 to 2018, VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences, Inc. from 2018 to 2019, and Controller at Merrimack Pharmaceuticals, Inc. from 2014 to 2017.
Education includes undergraduate and graduate degrees from Bentley University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-12 | 7,500 ( 0.01% ) | 9 225 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 2024-08-30 |
| Companies | Position | End |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 2018-04-30 |
| MERRIMACK PHARMACEUTICALS | Comptroller/Controller/Auditor | 2016-12-31 |
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2014-06-30 |
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 2019-03-04 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Genocea Biosciences, Inc.
Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions